Endothelial progenitor cells: A new target for the prevention of cardiovascular diseases

European Journal of Preventive Cardiology

Volumn 13, Issue 5, 2006, Pages 705-710

  Brixius, Klara ^a   Funcke, Fabienne ^a   Graf, Christine ^a   Bloch, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

coronary artery disease; endothelial progenitor cells; exercise; review; stem cell therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SURVIVAL; CELL TRANSPLANTATION; CELL TYPE; CLINICAL TRIAL; DRUG MECHANISM; ENDOTHELIUM CELL; EXERCISE; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; THROMBOSIS;

CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; STEM CELLS;

EID: 33749014635     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000221862.34662.31     Document Type: Article

References (75)

1. Billups KL. Erectile dysfunction as an early sign of cardiovascular disease Int J Impot Res 2005; 17(suppl 1):S19–24.
2. Diaz-Buxo JA, Woods HF. Protecting the endothelium: A new focus for management of chronic kidney disease. Hemodial Int 2006; 10: 42–48.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.
4. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362–367.
5. Korbling M, Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med 2003; 349: 570–582.
6. Orlic D. Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Ann NY Acad Sci 2003; 996: 152–157.
7. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005; 45: 321–325.
8. Rumpold H, Wolf D, Koeck R, Gunsilius E. Endothelial progenitor cells: a source for therapeutic vasculogenesis? J Cell Mol Med 2004; 8: 509–518.
9. Rehman J, Li J, Orschell CM, March KL. Peripheral blood ‘endothelial progenitor cells’ are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164–1169.
10. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J., et al Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 2001; 49: 671–680.
11. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 2003; 100: 2426–2431.
12. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, et al Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004; 24: 288–293.
13. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004; 35: 2378–2384.
14. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, et al Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752–2760.
15. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers G.L., Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 2001; 115: 186–194.
16. Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med 1999; 340: 115–126.
17. Schwartz SM, Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci U S A 1976; 73: 651–653.
18. Op den Buijs J, Musters M, Verrips T, Post JA, Braam B, van Riel N. Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol 2004; 287: H2651–H2658.
19. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221–228.
20. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function?. Cell 2001; 105: 829–841.
21. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422–3427.
22. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, et al Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634–637.
23. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, et al Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005; 105: 199–206.
24. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, et al Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776–2779.
25. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593–600.
26. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1–E7.
27. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S, et al Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442–1447.
28. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2005; 10: 9.
29. Humpert PM, Eichler H, Lammert A, Hammes HP, Nawroth PP, Bierhaus A, et al Adult vascular progenitor cells and tissue regeneration in metabolic syndrome Vasa 2005; 34: 73–78, 80.
30. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, Zhu JH. Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 2004; 107: 273–280.
31. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999–1007.
32. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004; 109: 1615–1622.
33. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, et al Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000; 87: 728–730.
34. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009–3017.
35. Stamm C, Kleine HD, Westphal B, Petzsch M, Kittner C, Nienaber CA, et al CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 2004; 52: 152–158.
36. Wollert KC, Drexler H. Cell therapy for acute myocardial infarction: where are we heading?. Nat Clin Pract Cardiovasc Med 2004; 1: 61.
37. Dobert N, Britten M, Assmus B, Berner U, Menzel C, Lehmann R, et al Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging 2004; 31: 1146–1151.
38. Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich KW, et al Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005; 97: 756–762.
39. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964–3972.
40. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697–703.
41. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858–864.
42. Morimoto A, Sakata Y, Watanabe T, Murakami N. Leucocytosis induced in rabbits by intravenous or central injection of granulocyte colony stimulating factor. J Physiol 1990; 426: 117–126.
43. Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, et al Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004; 363: 751–756.
44. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 1990; 87: 5978–5982.
45. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, et al Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci U S A 1994; 91: 3974–3978.
46. Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, et al Erythropoietin regulates endothelial progenitor cells. Blood 2004; 103: 921–926.
47. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, et al Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340–1346.
48. Smith KJ, Bleyer AJ, Little WC, Sane DC. The cardiovascular effects of erythropoietin. Cardiovasc Res 2003; 59: 538–548.
49. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001; 108: 391–397.
50. Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001; 108: 399–405.
51. Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, et al Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 2004; 110: 1933–1939.
52. Wang CH, Ciliberti N, Li SH, Szmitko PE, Weisel RD, Fedak PW, et al Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 2004; 109: 392–400.
53. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005; 45: 526–529.
54. Hakim AA, Petrovitch H, Burchfiel CM, Ross GW, Rodriguez BL, White LR, et al Effects of walking on mortality among nonsmoking retired men. N Engl J Med 1998; 338: 94–99.
55. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, et al Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002; 347: 716–725.
56. Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 2001; 37: 1891–1900.
57. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, et al Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA 2000; 283: 3095–3101.
58. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R, et al Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98: 2709–2715.
59. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93: 210–214.
60. Laufs U, Urhausen A, Werner N, Link A, Endres M, Wassmann S, et al Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220–226.
61. Adams V, Lenk K, Linke A, Lenz D, Erbs S, Sandri M, et al Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 2004; 24: 684–690.
62. Laufs U, Urhausen A, Werner N, Scharhag J, Heitz A, Kissner G, et al Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur J Cardiovasc Prev Rehabil 2005; 12: 407–414.
63. Morici G, Zangla D, Santoro A, Pelosi E, Petrucci E, Gioia M, et al Supramaximal exercise mobilizes hematopoietic progenitors and reticulocytes in athletes. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1496–1503.
64. Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, Buerk DG, et al Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol 2006; 290: H1378–H1386.
65. Steiner S, Niessner A, Ziegler S, Richter B, Seidinger D, Pleiner J, et al Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 2005; 181: 305–310.
66. Sandri M, Adams V, Gielen S, Linke A, Lenk K, Krankel N, et al Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 2005; 111: 3391–3399.
67. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, et al CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 2004; 110: 1209–1212.
68. George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A, et al Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 2004; 25: 1003–1008.
69. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, et al Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981–2987.
70. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45: 1441–1448.
71. Imanishi T, Hano T, Nishio I. Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells. Hypertens Res 2005; 28: 263–271.
72. Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97–104.
73. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005; 23: 1831–1837.
74. Rehman J, Li J, Parvathaneni L, Karlsson G, Panchal VR, Temm CJ, et al Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 2004; 43: 2314–2318.
75. Muller-Ehmsen J, Schmidt A, Krausgrill B, Schwinger RHG, Bloch W. Role of erythropoietin for angiogenesis and vasculogenesis: from embryonic development through adulthood. Am J Physiol Heart Circ Physiol 2006; 290: H331–H340.